What is already known about this topic? Many phenotypes of asthma have been identified in previous cluster analyses, mostly on the basis of cross-sectional data with limited inclusion of patients. Some studies have provided short-term 1-to 3-year prognosis for the phenotypes.
How does this study impact current management guidelines? Information on long-term outcome of asthma can be used to inform and motivate patients. We show the poorest outcome and the most unmet needs in the therapy of smoking and obesity-related asthma, suggesting need for special guidance.
BACKGROUND: Previous cluster analyses on asthma are based on cross-sectional data. OBJECTIVE: To identify phenotypes of adult-onset asthma by using data from baseline (diagnostic) and 12-year follow-up visits. METHODS: The Seinäjoki Adult Asthma Study is a 12-year follow-up study of patients with new-onset adult asthma. K-means cluster analysis was performed by using variables from baseline and follow-up visits on 171 patients to identify phenotypes. RESULTS: Five clusters were identified. Patients in cluster 1 (n [ 38) were predominantly nonatopic males with moderate smoking history at baseline. At follow-up, 40% of these patients had developed persistent obstruction but the number of patients with uncontrolled asthma (5%) and rhinitis (10%) was the lowest. Cluster 2 (n [ 19) was characterized by older men with heavy smoking history, poor lung function, and persistent obstruction at baseline. At follow-up, these patients were mostly uncontrolled (84%) despite daily use of inhaled corticosteroid (ICS) with add-on therapy. Cluster 3 (n [ 50) consisted mostly of nonsmoking females with good lung function at diagnosis/ follow-up and well-controlled/partially controlled asthma at follow-up. Cluster 4 (n [ 25) had obese and symptomatic patients at baseline/follow-up. At follow-up, these patients had several comorbidities (40% psychiatric disease) and were treated daily with ICS and add-on therapy. Patients in cluster 5 (n [ 39) were mostly atopic and had the earliest onset of asthma, the highest blood eosinophils, and FEV 1 reversibility at diagnosis. At follow-up, these patients used the lowest ICS dose but 56% were well controlled. CONCLUSIONS: Results can be used to predict outcomes of patients with adult-onset asthma and to aid in development of Adult-or late-onset asthma has been suggested to be a distinctive phenotype of asthma. 1, 2 Patients with adult-onset asthma have lesser allergic processes, lower lung function despite shorter duration of disease, and more often a pronounced eosinophilic inflammation without evidence of T H 2eassociated inflammation when compared with patients with childhoodonset asthma. 1 These findings suggest that adult-onset asthma is more heterogeneous when compared with childhood-onset asthma. In previous studies, subphenotypes of adult-onset asthma such as eosinophil-predominant, mild to moderate well-controlled, obesity-related, smoking, and severe obstructive asthma have been proposed. 3, 4 To identify phenotypes of asthma, unsupervised hierarchical cluster analyses have been carried out. However, the cluster analyses have mostly been based on cross-sectional data on patients with mixed duration of asthma. 2, [4] [5] [6] Asthma is known as a disease with a high degree of variability, making one time point a fragile basis for cluster analysis. Furthermore, no information on the diagnostic phase has been included in the previous analyses. In addition, many previous analyses have clustered patients with severe asthma, 7, 8 leaving milder forms with less attention. Some studies have involved short follow-ups (1-3 years). 6, 7, 9, 10 In a previous prospective longitudinal analysis of severe asthma, the clusters did not show cluster-specific disease courses regarding outcome of asthma, suggesting a potential limitation in the way of performing current cluster analyses. 9 In addition to the natural disease variability, many factors such as therapy, lifestyle, and comorbidities may modify the disease course. Reliability of the results of a cluster analysis would be increased by including clinical data from several time points of the disease follow-up into the analysis.
Here, we used a long-term follow-up approach to construct phenotypes of adult-onset asthma by carrying out a cluster analysis with inclusion of variables from diagnosis to a 12-year follow-up visit. This approach provides novel insights into the phenotypes of asthma with prognostic significance.
METHODS

Patients and study design
The present study was part of the Seinäjoki Adult Asthma Study (SAAS), which is a prospective, single-center (Seinäjoki Central Hospital, Seinäjoki, Finland), 12-year follow-up study of a cohort of consecutive white patients having new-onset asthma diagnosed at adult age (!15 years). SAAS has been registered on ClinicalTrials.gov with ID NCT02733016. Institutional permissions (TU1114 and LET) were obtained and the participants gave written informed consent to the study protocol approved by the Ethics Committee of Tampere University Hospital, Tampere, Finland (R12122). The protocol, inclusion and exclusion criteria, and the background data of SAAS have been published elsewhere. 11 Briefly, asthma was diagnosed by a specialized respiratory physician during the period 1999 to 2002 on the basis of typical clinical symptoms and confirmed by objective lung function measurements. 11, 12 The main diagnostic features of asthma in each cluster are presented in Table E1 in this article's Online Repository at www.jaci-inpractice.org. Smokers and patients with comorbidities were not excluded. After diagnosis, the patients were treated and monitored in specialized or primary care as required. The total cohort consisted of 257 patients and 203 patients completed the follow-up visit (mean follow-up time, 12.2 years; range, 10.8-13.9 years). At 12-year follow-up visit, asthma status and disease control, comorbidities, and medication were evaluated using structured questionnaires and lung function was measured. Data on asthma-related visits to health care and hospitalizations were also collected from primary care, occupational health care, private clinics, and hospitals. After excluding those with missing data, 171 patients with adult-onset asthma remained in the cohort for cluster analysis (Figure 1 ).
Lung
function, comorbidities, inflammatory parameters, and other clinical measurements Lung function was measured with a spirometer according to international recommendations. 13 The following were the lung function measurement points: (1) baseline (time of asthma diagnosis), (2) the maximum prebronchodilator FEV 1 (Pre-BD FEV 1 ) during the first 2.5 years after diagnosis (Max 0-2.5 ) (and after start of anti-inflammatory therapy), and (3) 12-year follow-up.
14 Detailed information on determination of lung function, inflammatory parameters, and comorbidities can be found in this article's Online Repository at www.jaci-inpractice.org. Asthma control was assessed according to the Global Initiative for Asthma 2010 report. 15 Patients filled out the Airways Questionnaire 20 (AQ20) at baseline visit and AQ20 and asthma control test (ACT) questionnaires at the followup visit. The AQ20 is a short and simple well-validated questionnaire to measure and quantify disturbances in the airway-specific quality of life. 16 ACT is a widely used patient self-administered tool for identifying those with poorly controlled asthma. 17 
Variable selection
Input variables for the cluster analysis were selected on the basis of factor analysis (see Table E2 in this article's Online Repository at www.jaci-inpractice.org). Basic and clinical variables included in factor analysis were chosen to cover as wide a range as possible from diagnosis to 12-year follow-up visit and are further discussed in this article's Online Repository at www.jaci-inpractice.org. the number of clusters. Then, K-means analysis was carried out by using the prespecified number of clusters (5) . Stepwise discriminant analysis was performed to identify variables discriminating between the prespecified clusters. Statistically significant results were expected for most of the comparisons because the objective of the cluster analysis was to differentiate the participants into distinct phenotypes of adult-onset asthma.
Other statistical analyses
Continuous data are expressed as mean AE SD or median and interquartile range. Group comparisons were performed by 1-way analysis of variance with the Tukey post hoc test, the KruskalWallis test, or the chi-square test. Statistical analyses were performed by using SPSS software, version 22 (IBM Corporation, Armonk, NY) and MATLAB, version 8.6 (Mathworks, Natick, Mass).
RESULTS
Patients' characteristics
Characteristics of the total cohort at baseline and follow-up are presented in Table E3 in this article's Online Repository at www. jaci-inpractice.org. Patients were mostly females (58.5%) and nonatopic (63.5%), with age at asthma onset ranging from 15 to 77 years. At diagnosis, most patients were steroid-naive. At the 12-year follow-up point, 78.9% were daily users of inhaled corticosteroid (ICS) and 50.9% were daily users of ICS and add-on medication.
Cluster analysis
By performing Ward hierarchical and K-means cluster analyses, 5 clusters were identified. The basic characteristics of these clusters are shown in Figure 2 . Cluster 1 was characterized by low prevalence (10.5%) of rhinitis (nonrhinitic asthma), whereas cluster 2 had the highest smoking history (smoking asthma). Cluster 3 consisted mainly (98%) of women (female asthma), and most patients in cluster 4 were obese from diagnosis to 12-year follow-up visit (obesity-related asthma). Cluster 5 mostly included atopic patients with the earliest onset of asthma (earlyonset atopic adult asthma). Basic and clinical characteristics of the clusters at baseline and at follow-up are presented in Tables I-IV. There were no major differences in the main diagnostic features between groups (see Table E1 in this article's Online Repository at www.jaci-inpractice.org).
Cluster 1: Nonrhinitic asthma. Cluster 1 (n ¼ 38 [22.2%] ) was characterized by lack of rhinitis, male predominance (60.5%), onset of asthma at middle age, and second highest smoking history (Figure 2 ). Proportion of patients with permanent bronchial obstruction (post-BD FEV 1 /forced vital capacity [FVC] <0.7) increased from 10.8% to 39.5% from diagnosis to 12-year follow-up visit. This cluster also showed the highest weight gain, with the proportion of obese patients increasing from 18.4% to 39.5%. Asthma was uncontrolled in only 5.3% of the patients, even though most (55.9%) were treated with low-dose ICS or no daily ICS (Table I) . Cluster 1 showed moderate loss of FEV 1 during the follow-up and the lowest use of health care (Figures 3 and 4) . Patients had 1 comorbidity on average at the 12-year follow-up visit, the most prevalent being chronic obstructive pulmonary disease (COPD) and hypertension (Table IV) .
Cluster 2: Smoking asthma. Cluster 2 was the smallest cluster (n ¼ 19 [11.1%] ) and was predominated by older males. Almost 80% of patients had smoking history and 44.4% showed bronchial obstruction at diagnosis and could be characterized as having asthma-COPD overlap syndrome (ACOS). 18 However, the smoking cluster did not differ from other clusters on the basis of diffusing capacity. The patients had poor lung function, high symptoms, and uncontrolled asthma despite 94.7% being under daily ICS therapy, 73.4% with moderate-to high-dose ICS, and 78.9% with long-acting b 2 agonist at follow-up. Even though lung function significantly improved after start of therapy, the annual decline in FEV 1 was steep (78 mL on average) from the maximum point of lung function to the 12-year follow-up visit ( Figure 4 ; Table II ). This was the only group with no decrease in blood eosinophils or symptoms from diagnosis to follow-up ( Figure 4 ). The patients had 3 comorbidities on average (Table IV) and frequent health care use (Figure 3 ). Of the patients, 36.8% had been hospitalized for asthma (Figure 3 , B) and this cluster accounted for 35.8% of all hospital treatment periods.
Cluster 3: Female asthma. This group was the largest (n ¼ 50 [29.2%] ) and consisted of women with a wide range in the age of asthma onset. Cluster 3 contained more (44%) patients with normal weight (body mass index <25) compared with other clusters and showed the lowest smoking history. Forty percent reported being symptomatic already during childhood even though they were not diagnosed as having asthma. Pre-BD FEV 1 was normal (>80% predicted) in 78% at diagnosis and in 90% at follow-up, and the annual decline in FEV 1 was the lowest (31 mL). Blood eosinophils were the second highest and the AQ20 symptom score was at a rather moderate level of 6 out of 20 at diagnosis, and both reduced during the follow-up ( Figure 4 ). Even though lung function measured by spirometry and inflammation were within normal range and 78% were undergoing ICS treatment at the 12-year follow-up visit, 64% of the patients were partially controlled or uncontrolled and health care use was relatively high (Table I; Figure 3 ). Female cluster accounted for 29.0% of all asthma-related visits. Visits to healthcare Hospitalizations FIGURE 1. Flow chart of the study.
J ALLERGY CLIN IMMUNOL PRACT VOLUME 5, NUMBER 4 of asthma onset. On average, patients were obese from diagnosis to the 12-year follow-up point without gaining more weight during this time. The patients were multimorbid at follow-up (Table IV) , with the most prevalent comorbidities being hypertension, diabetes, and psychiatric diseases. Asthma was uncontrolled in 48% of the patients at follow-up even though 92% were undergoing ICS treatment, 50% used high-dose ICS, and 72% were on add-on medication (Table I) . At diagnosis, 44% showed pre-BD FEV 1 of more than 80% predicted. Lung function improved on start of therapy and remained relatively stable throughout follow-up (Figure 4 , A). Respiratory symptoms, use of oral steroids, and health care use were all at high levels ( Figures 3 and 4 ).
Cluster 5: Early-onset atopic adult asthma. This group was the second largest (n ¼ 39 [22.8%] ) and consisted of the youngest patients with mean age of asthma onset at 33 AE 11 years. Almost half had suffered from respiratory symptoms during childhood, 59% were atopic, and 90% had nonallergic or allergic rhinitis (Table I) . Of this cluster, 59% showed pre-BD FEV 1 of more than 80% at diagnosis and 84% could be reversed to FEV 1 of more than 80% predicted by BD. Reversibility was in general the highest. Lung function initially showed a good response to steroids, even though the loss of lung function after the maximum point was also the second steepest. At diagnosis, these patients showed the highest blood eosinophils (Table III) , which reduced until the 12-year followup visit ( Figure 4 ). Asthma was controlled in 56% of the subjects and use of medication was the lowest, because 56% were using low-dose ICS or no medication and only 17.9%
were treated by long-acting b 2 agonist (Table I) . Use of steroid bursts was infrequent and use of health care was among the lowest ( Figure 3 ).
Validation
For validation, we carried out K-means algorithm 10 times by the leave-one-out method to ensure stability and repeatability of the model. This method showed 94.4% repeatability.
Discriminant analysis
By using a stepwise method of discriminant analysis, 12 out of 17 variables were found to significantly discriminate between the clusters: the diagnostic variables were post-BD FEV 1 /FVC, FEV 1 reversibility, and maximal change in FEV 1 (from diagnosis to Max 0-2.5 ), whereas the follow-up variables included rhinitis, number of drugs in use to treat comorbidities, pre-BD FEV 1 , pack-years, body mass index, limitation of activities (none/any), and basic variables of sex, age at asthma onset, and symptoms of asthma for less than 16 years, of which rhinitis, post-BD FEV 1 / FVC, number of drugs in use to treat comorbidities, and sex were found to be the strongest discriminating variables. Duration of symptoms before diagnosis, blood eosinophils and neutrophils, reversibility at follow-up, and ACT score were not found as statistically significant discriminants. The percentage of correct classification on the basis of the 12 discriminating variables was 94.7% (data not shown).
DISCUSSION
In this study, we identified phenotypes of adult-onset asthma by using longitudinal data and basic and clinical variables ranging from the diagnostic phase to the 12-year follow-up visit. Our cohort included smokers and patients with comorbidities. The following 5 phenotypes were identified: (1) nonrhinitic controlled to partially controlled asthma with low use of medication and health care; (2) smoking asthma or ACOS with poor lung function, high symptoms, and high use of medication and health care; (3) female asthma with normal clinical parameters 900 (800-1600) 800 (400-1000) 800 (700-1600) 900 (700-1400) 800 (400-1000) 800 (575-1000) 1000 (800-1400) 1000 (475-1525) 800 (800-1600) 800 (400-800 but relatively high use of health care; (4) obesity-related asthma with comorbidities, high symptoms, and high use of medication and health care; and (5) atopic well-controlled asthma with onset earlier in adulthood. Instead of characterizing phenotypes in one point of disease, we provide phenotypes based on 12-year follow-up data.
Our results show both similarities to and differences from those of previous cluster analyses based on cross-sectional data with mixed duration of asthma. Most previous analyses have excluded smokers or heavy smokers and only few have identified smoking asthma. 6, 19 Cluster A in the Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) study 6 resembled our smoking cluster in many respects. However, in our study, the smoking cluster showed an annual decline in FEV 1 that was the steepest of all groups in contrast to the results of the COREA smoking cluster in 1-year follow-up. Many negative outcomes previously associated with smoking asthma were evident in our smoking cluster, including lower asthma-related quality of life (based on AQ20 score), frequent health care use, and severe/uncontrolled asthma. [20] [21] [22] Even though the patients in the smoking cluster typically show irreversible airflow limitation and comorbidity profiles resembling that of COPD, normal average diffusing capacity in each cluster suggests that the main diagnosis is asthma and not emphysema. In addition, the diagnosis of asthma was made by a respiratory specialist and each patient fulfilled the diagnostic criteria of asthma including objective lung function measurements showing bronchial variability. This smoking group, although being the smallest one, was responsible for more than a third of all asthma-related hospitalizations, highlighting the significance of this group to health care costs. Obviously, much efforts should be focused on advising patients to stop smoking as early as possible, even before onset of asthma and before asthma turns from a milder form to difficult-to-treat smoking asthma with high burden for both individual and health care.
Obesity-related female-predominant asthma is a cluster identified in our study as well as in some previous studies, 2,5,7,10 and our results add by providing data on prognosis of the long-term obesity. Our results on this cluster support previous findings indicating frequent symptoms and exacerbations, high use of health care, high medication, and a nonatopic, noneosinophilic disease characteristic. This cluster is also prone to create a high burden to health care, as evidenced by the most frequent use of oral corticosteroids and of health care services. To further add on previous studies, we found the highest number of comorbidities in the obese cluster and especially a high prevalence of psychiatric comorbidity (40%). Consistently, in a previous study, the highest depression score was shown in the late-onset obese cluster in a cohort of severe asthma. 7 However, interaction between obesity, psychiatric diseases, and asthma requires further studies. 23, 24 Recently, we showed that multimorbidity is associated with increased symptoms of asthma, which may be partly related to systemic inflammation in these patients. 25 Systemic inflammation has been associated with high steroid dose in the treatment of adult-onset asthma. 25 Therefore, multimorbidity and systemic inflammation may be relevant in turning asthma into symptomatic and steroid-resistant in obese patients. However, weight loss has resulted in improved symptoms, lung function, asthma control, and health status, 23 suggesting that it would benefit this subgroup.
In addition to the obesity-related female-predominant group, we identified a nonobese cluster of females with good lung †P < .05 to all other clusters at corresponding time point (baseline or follow-up). zP < .05 vs cluster 5 at corresponding time point (baseline or follow-up). {P < .05 vs cluster 1 at corresponding time point (baseline or follow-up). xP < .05 vs cluster 2 at corresponding time point (baseline or follow-up). jjP < .05 vs cluster 3 at corresponding time point (baseline or follow-up). Paired comparison between baseline and follow-up is not shown. #At least 2 courses of oral steroids during the 2 previous years before the follow-up visit. **Baseline ICS users refer to those who used ICS daily before diagnosis. † †Baseline ICS dose is the starting dose at diagnosis. Low-dose ICS refers to 400 mg, medium-dose ICS to >400e800 mg, and high-dose ICS to >800 mg budesonide equivalents. function and a wide range in the age of asthma onset. The previously defined clusters "least severe asthma with normal lung function," "middle-age onset, female-dominant," and "late-onset mild asthma" 6, 7, 19 show resemblance to our female cluster, including predominance of nonobese females, normal lung function, 6, 7, 19 and stable lung function in the short followups. 6, 7 Low smoking history, low body mass index, low count of comorbidities, and high eosinophils at diagnosis may have affected the good overall prognosis of the female cluster. However, the health care use was relatively high in this group given that many clinical parameters were within normal range. This may be explained by females' stronger perception of symptoms and lower threshold to contact health care when compared with males. 26 In addition, female patients with similar severity of asthma as the corresponding male patients have shown better lung function but worse asthma-related quality of life. 26 In this cluster, lung function based on spirometry was more stable when compared with lung function in other groups, but peak expiratory flow follow-up might have shown variable obstruction and disease activity. In addition, whether parameters such as blood eosinophils or airway hyperresponsiveness better correlate to disease activity and symptoms remains unclear. In the female cluster, roughly half of the patients were at fertile age, and the other half at menopausal or postmenopausal age at asthma onset, suggesting that no uniform sex hormoneerelated mechanism explains the pathophysiology of asthma in this cluster. However, hormonal aspects probably play a significant role in the pathogenesis and course of the disease, [26] [27] [28] [29] [30] [31] even though the mechanisms are likely multifactorial. Presence of symptoms at childhood in 40% of the patients also suggests the involvement of T H 2-related mechanisms and some overlap with cluster 5.
Similar to previous findings, 32 most patients in our study had a coexisting allergic or nonallergic rhinitis. However, we also identified a nonatopic mild to moderate male-predominant asthma without rhinitis, which to our knowledge has not been reported previously. Despite the second highest smoking history, 40% prevalence of permanent bronchial obstruction, and obesity at follow-up, these patients had significantly better prognosis when compared with those in clusters 2 and 4. Rhinitis has been associated with more severe asthma, 32, 33 suggesting that lack of rhinitis is a significant determinant associated with the favorable prognosis in this group. Male predominance, moderate smoking history, and the highest weight gain suggest that pathophysiological mechanisms in this cluster are related to those features. Asthma in obese men has been reported to be less often severe when compared with that in obese women 26 and obesity-related asthma may have important sex-specific differences concerning the mediators of the disease. 34, 35 For example, in a recent study, no similar difference existed in systemic inflammation between nonobese and obese males as seen in females. 35 Lower level of systemic inflammation could also contribute to lesser number of comorbidities and better prognosis of asthma. Further studies are needed to evaluate the pathophysiological mechanisms in this cluster.
Cluster 5 in our study fits well with the previous findings of the important role of age of onset in defining the phenotype. 1, 3 Atopy, childhood symptoms, earliest onset of asthma, good steroid-responsiveness, and large FEV 1 reversibility support the conclusion that this cluster represents the traditional early-onset asthma but starting at early adulthood. In addition, the good prognosis strengthens the view. 36 A corresponding adult-onset group was recognized in the COREA study 6 and many studies have recognized childhood-onset atopic asthma. 5, 7, 10 A rather high annual lung function decline was seen after the reach of maximum point but this may be related to lung capacity because higher reversibility and higher maximal FEV 1 enable higher decline in lung function. More than 70% of the patients were daily users of ICS and most were well controlled at follow-up, suggesting good compliance to treatment. Poor compliance was suspected to explain poorer outcome of early-onset asthma in a previous study. 10 Because increased age has been associated with increased risk of severe asthma, 37 younger age may also significantly contribute to the good prognosis in this group.
In 2 previous studies, an eosinophilic inflammationpredominant late-onset cluster was identified in contrast to our findings. One reason for the absence of this group may be the absence of sputum eosinophil measurements in our study and its absence as an input variable of cluster analysis, which is considered as a limitation of our study.
2,10 However, use of .05, **P <.01, and ***P <.001, at left side DFEV 1 from diagnosis to Max 0-2.5 , and at right side DFEV 1 from Max 0-2.5 to 12-y follow-up visit within the cluster. In B and C: *P < .05, **P < .01, and ***P < .001 of DFEV 1 from diagnosis to follow-up visit within each cluster. blood eosinophils and fractional exhaled nitric oxide is supported by a recent study showing that airway eosinophilia in adult patients can be reliably and accurately identified by blood eosinophils and fractional exhaled nitric oxide instead of induced sputum, and the accuracy is similar in different phenotypes. 38 Furthermore, in the previous study, 2 there was speculation on nonadherence, which might lead to persistent eosinophilia, and on overrepresentation of severe asthma because of the recruitment process. Previous studies with patients with adult-onset asthma have recognized larger groups of late-onset benign asthma, 2,6,10 but our study gives a more detailed analysis of the population with mild to moderate asthma by separating it into 3 clusters (female, nonrhinitic, and atopic). Our approach reveals specific features of the prognoses of these groups that may more closely reflect the underlying pathobiology.
Our study has many strengths. Inclusion of diagnostic data gives the clinician more accurate tools to evaluate the phenotype of asthma at early phase, which helps to plan future therapy and follow-up. Wide inclusion of patients, including heavy smokers, multimorbid patients, and all severities of asthma makes our analysis clinically significant and close to real life. Limitations to this study also exist. Subjectivity cannot be avoided because variables included in factor or cluster analysis had to be selected as well as the method of cluster analysis. However, every effort was made to avoid bias due to subjectivity, for example, wide inclusion of clinical and basic variables to factor analysis and predominantly factor analysisebased selection of variables to cluster analysis. One can also argue about the small size of the cohort, being, however, comparable with many previous studies.
2,10
Altogether, we identified 5 clusters of adult-onset asthma with clinical relevance and clear basic characteristics and with 12-year prognosis (Table V) . To our knowledge, this is the first study using long-term data in the construction of clusters, and is the first to succeed in identifying clusters with different disease prognoses. These results can be used in clinics to predict outcomes of patients with adult-onset asthma and to plan medication and follow-up. In addition, our results may aid in the development of personalized therapy. Even though this study concentrated on defining the clinical phenotypes, the results are encouraging when considering the possible pathobiological similarities within each cluster, being an important goal in future studies. Comorbidities. Comorbidities were self-reported or based on self-reported medication, and their definitions and classifications were based on previous studies.
E3,E4 Unclear cases were confirmed from patient records. Conditions included as comorbidities were hypertension, depression, painful condition (daily use of analgesic medication), coronary heart disease, treated dyspepsia (daily medication), diabetes, thyroid disorders, rheumatoid arthritis, and other inflammatory polyarthropathies and systematic connective disorders, anxiety and other stressrelated and somatoform disorders, irritable bowel syndrome, cancer, treated constipation, stroke and transient ischemic attack, chronic kidney disease, diverticular disease of the intestine, atrial fibrillation and other cardiac arrhythmias, peripheral vascular disease, heart failure, prostate disorders, glaucoma, epilepsy, dementia, schizophrenia/nonorganic psychosis or bipolar disorder, psoriasis, inflammatory bowel disease, migraine, bronchiectasis, Parkinson disease, multiple sclerosis, viral hepatitis, and chronic liver disease. Alcohol problems, anorexia or bulimia, misuse of psychoactive substance, hearing loss, and blindness or low vision were left out because the presence of these conditions could not be assessed on the basis of patients' self-reports.
Variable selection for factor analysis and cluster analysis. Fifty-one variables from the following 3 time points were included in factor analysis: diagnosis, time of Max 0-2.5 , and 12-year follow-up visit. Variables included were related to lung function, reversibility, symptoms (AQ20 and ACT scores, Global Initiative for Asthma control assessment, duration of respiratory symptoms before diagnosis of asthma, and childhood respiratory symptoms), basic variables (body mass index, Dbody mass index, age of asthma onset [at asthma diagnosis], sex, and smoking), comorbidities, atopy and rhinitis, inflammatory parameters (fractional exhaled nitric oxide, blood eosinophils, blood neutrophils, and total IgE), diffusing capacity, workrelated asthma (defined by the question "Does your asthma aggravate during working day?"), aspirin-sensitive asthma, and ACOS. Use of medication (ICS dose and asthma medication) and health care use were included as composite variables. The composite variable constructed on the basis of the use of asthma medication was the following: 1 ¼ only short-acting b 2 agonist when needed, 2 ¼ daily ICS, 3 ¼ daily ICS and one add-on drug, 4 ¼ daily ICS and more than 1 add-on drug, and 5 ¼ daily ICS and oral steroid and/or omalizumab. Use of the health care composite variable was scaled on the basis of frequency of visits to the emergency department, oral corticosteroid courses, or absence from school or work (at least 1 of these): 1 ¼ none, 2 ¼ less than once a year, 3 ¼ once a year, and 4 ¼ more than once a year.
When choosing variables for cluster analysis, the variable with the highest loading was selected from each factor with an eigenvalue higher than 1.2 with few exceptions (Table E2) . Logarithmic transformations were carried out for continuous variables when applicable. Categorical variables were converted into binary (0/1) variables. All variables were converted into z scores for cluster analysis. 
